Turing Pharmaceuticals said that it won't cut the list price of the drug. However, it will negotiate discount price with hospital. Last September, Turing Pharmaceuticals raised the price of live-saving drugs, Daraprim by more than fifty times.
Tags: Hedge fund
Archegos Founder Bill Hwang Found Guilty of Securities Fraud
Defunct hedge fund firm Archegos Capital Management founder Bill Hwang has been found guilty of securities and market manipulation fraud which prosecutors claimed cost global investment banks billions.
Chinese Hedge Fund Zhejiang Ruifengda Under Investigations Over Suspected Illegal Activities
China's securities watchdog is investigating Zhejiang Ruifengda Asset Management Co. due to allegations of illegal activities, including failing to repay investors and a missing controlling shareholder, as the hedge fund manages assets exceeding $469 million.
Japan's banking woes may hit global markets
The turbulent situation Japan's banking sector is likely to impact global markets. A leading hedge fund manager says that collapse in the Japan's banking industry blindsides the market, while shrugging off any possibility of banking crisis in the world's third largest economy.
Perry Capital Delays In Investment Eyeing Another Credit Event Like 2008
Perry Capital has recently invested $1 billion in investment grade bonds. The investment firm possesses a hedge fund of $10 billion and prepared to make investment. But Perry Capital leader Richard Perry waits for the suitable moment of investment.
Latest News
Top U.S. hedge fund management firms, including David Einhorn's Greenlight Capital and Philippe Laffont's Coatue Management, reduced their stakes in Apple Inc during the fourth quarter, ahead of the iPhone maker's strong rally in 2015, according to regulatory filings.
Several of the biggest hedge fund managers slashed or dissolved their stake in China's Alibaba Group Holding Ltd at the end of last year, taking a prescient bet ahead of the company's surprise revenue miss last quarter that sent shares plunging in late January.
A fast-growing segment of U.S. retirement plans is using hedge-fund type strategies to bet a small but increasing slice of their assets.
Hedge funds specializing in bets on mergers and acquisitions are starting to see investors withdraw funds, prompting them to take a more cautious approach after being caught out by more than 500 corporate deals globally failing this year.
Leland Lim, a former partner at Goldman Sachs Group Inc, is planning to form his own hedge fund, according to sources with knowledge of the situation interviewed by Bloomberg.
PCA Investments have decided to close a multistrategy hedge fund after China's sovereign wealth fund China Investment Corp withdrew its support, according to sources interviewed by Bloomberg.
With its 25.2% gain, activist investor Daniel Loeb's Third Point beat rivals in 2013, Reuters reported. Loeb's hedge fund stayed in line with the Standard & Poor's 500 Index which rose 29.6% in the same period.
Marathon Asset Management, the New York-based hedge fund that owns the town of Scotia in California needs to make a slick exit, The Wall Street Journal reported.
Roshan Padamadan, a former HSBC Holdings Plc product specialist, has started a hedge fund that will seek for opportunities in global liquid securities, Bloomberg reported.
